Jasper Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD for 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Jasper Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate for 2021.
  • Jasper Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2M, a 43.2% increase year-over-year.
Share-based Payment Arrangement, Expense, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $4K Jan 1, 2021 Dec 31, 2021 10-K 2022-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.